Program Overview
Program covers recent advances in the diagnosis and management of glomerular disease in a one-day course.
Brought to you from the:

Learning Objectives
-Identify Current Treatment Guidelines for Glomerular Diseases.
-Explore Targeted Therapies for C3G, IgA Nephropathy, and ANCA Vasculitis.
-Assess the Role of SGLT2 Inhibitors in Non-Diabetic Glomerular Diseases.
-Discuss Monitoring and Management of Treatment-related Adverse Events.
-Review Case Studies and Real-world Scenarios.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live virtual activity for a maximum of 7.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
PAs may claim a maximum of 7.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.